Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

(±)14(15)-DiHETE

  • Zoom
    (±)14(15)-<wbr/>DiHETE
  • (±)14(15)-<wbr/>DiHETE
Cat No: 10006998
Biochemicals - Lipids
Cayman

(±)14(15)-DiHETE is an oxylipin and a metabolite of the ω-3 fatty acid eicosapentaenoic acid (EPA; Item Nos. 90110
90110.1
21908).{49321,49322} It is formed via cytochrome P450-mediated epoxidation of EPA to (±)14(15)-EpETE (Item No. 10173), follo...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • (±)14,15-dihydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid
Correlated keywords:
  • epoxygenases metabolites EPA eicosapentaenoic acids epoxidations hydroxylations w-3 .omega.-3 fatty acids marine organisms incubated rats livers microsomes colitis homogenates cytochromes P450-catlyzed epoxidations w-6 .omega.-6 double bonds conversion vicinal diols epoxides hydrolases excreted excretion humans ingesting fish oils supplements 14,15-dihete
Product Overview:
(±)14(15)-DiHETE is an oxylipin and a metabolite of the ω-3 fatty acid eicosapentaenoic acid (EPA; Item Nos. 90110
90110.1
21908).{49321,49322} It is formed via cytochrome P450-mediated epoxidation of EPA to (±)14(15)-EpETE (Item No. 10173), followed by conversion of the epoxide to a diol by soluble epoxide hydrolase.
Size 25 µg
Shipping dry ice
Molecular Formula C20H32O4
SMILES CC/C=C\C[C@@H](O)[C@H](O)C/C=C\C/C=C\C/C=C\CCCC(O)=O
Molecular Weight 336,5
Formulation A solution in ethanol
Purity ≥98%
Custom Code 2916.19
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : (±)14(15)-<wbr/>DiHETE There are 10 products.

Search